Drug Search Results
More Filters [+]

BAT CAR-T - Dynamic Cell Therapies

Alternative Names: BAT CAR-T - Dynamic Cell Therapies
Latest Update: None
Latest Update Note: None

Product Description

Dynamic Cell Therapies is developing controllable CAR T cells to address difficult-to-treat cancers. Our platform technology of dynamic control of engineered T cells will improve the safety, efficacy, and durability of CAR T cell therapies. This system will have immediate applications in hematological cancers, with future approaches in solid tumors and autoimmune diseases. (Sourced from: https://www.dynamiccelltherapies.com/)

Mechanisms of Action: CAR-T,IL7

Novel Mechanism: Yes

Modality: Cell Therapy

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Dynamic Cell Therapies
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for BAT CAR-T - Dynamic Cell Therapies

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 0: Multiple Myeloma|Acute Myeloid Leukemia

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title